Salter Labs has launched a portfolio of medical products designed for use on babies in neonatal ICUs and pediatric care facilities, according to a company announcement. The company recently debuted the products at both the 2015 National Association of Neonatal Nurses meeting and AARC 2015.
The company has also said it received 510(k) clearance from the FDA for the CPAP Cannulaide Securement Device, the only device cleared by the FDA to enhance the CPAP seal in neonatal nasal CPAP therapy, Salter says.
It’s new line of NICU and pediatric respiratory devices include:
- Neonatal nasal CPAP and oxygen securement devices that protect neonates’ skin and enhance the seal created by CPAP cannulas;
- Endotracheal tubes with polyurethane thin cuffs and flexible tips for easier intubation that lessen the chance of airway trauma;
- Divided capnography cannulas with sizes to fit infants and children of all ages;
- High-performance aerosol nebulizers that may reduce treatment time and hospital admissions; and
- Aerosol masks for inhaler therapy designed based on laser-mapping of babies’ faces for a better, softer fit.
“Babies in the NICU and in children’s hospitals deserve products made just for them. I’m thrilled to see Salter develop products just for babies and children that address their special needs; their products have softer and safer materials, a comfortable fit, and help promote effective and compassionate care,” said Michelle Waddell, RN, BS, RNC-NIC, neonatal clinical consultant.